These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study. Cappato R Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843 [TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258 [TBL] [Abstract][Full Text] [Related]
5. Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study. Tsai CT; Huang SK; Lin JL; Lai LP; Pacing Clin Electrophysiol; 2003 Nov; 26(11):2083-90. PubMed ID: 14622308 [TBL] [Abstract][Full Text] [Related]
6. Why the antiarrhythmics versus implantable defibrillator (AVID) trial sets the wrong precedent. Fogoros RN Am J Cardiol; 1997 Sep; 80(6):762-5. PubMed ID: 9315584 [No Abstract] [Full Text] [Related]
7. Evaluating AVID, CASH, CIDS, CABG-patch and MADIT: are they concordant? Böcker D; Breithardt G J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():103-8. PubMed ID: 10590496 [No Abstract] [Full Text] [Related]
8. There should never be another antiarrhythmics versus implantable defibrillator (AVID) trial. Singer I; Nisam S Am J Cardiol; 1997 Sep; 80(6):766-8. PubMed ID: 9315585 [No Abstract] [Full Text] [Related]
9. Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis. Hallstrom AP; Wyse DG; McAnulty J; ; J Interv Card Electrophysiol; 2008 Dec; 23(3):159-66. PubMed ID: 18810620 [TBL] [Abstract][Full Text] [Related]
10. The implantable cardioverter-defibrillator: does everybody need one? Raj SR; Sheldon RS Prog Cardiovasc Dis; 2001; 44(3):169-94. PubMed ID: 11727276 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study. Farré J; Cabrera JA; Romero J; Rubio JM Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100 [TBL] [Abstract][Full Text] [Related]
12. Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian implantable defibrillator study implantable cardioverter defibrillatory efficacy score in the antiarrhythmics versus implantable defibrillators trial. Exner DV; Sheldon RS; Pinski SL; Kron J; Hallstrom A Am Heart J; 2001 Jan; 141(1):99-104. PubMed ID: 11136493 [TBL] [Abstract][Full Text] [Related]
13. The AVID trial: evidence based or randomized control trials--is the AVID study too late? Antiarrhythmics Versus Implantable Defibrillators. Josephson ME; Nisam S Am J Cardiol; 1997 Jul; 80(2):194-7. PubMed ID: 9230158 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Owens DK; Sanders GD; Harris RA; McDonald KM; Heidenreich PA; Dembitzer AD; Hlatky MA Ann Intern Med; 1997 Jan; 126(1):1-12. PubMed ID: 8992917 [TBL] [Abstract][Full Text] [Related]
15. Primary prevention of sudden cardiac death: the time of your life. Prystowsky EN Circulation; 2004 Mar; 109(9):1073-5. PubMed ID: 15007016 [No Abstract] [Full Text] [Related]
16. Clinical strategies for use of the implantable cardioverter defibrillator: the impact of current trials. Estes NA Pacing Clin Electrophysiol; 1996 Jul; 19(7):1011-5. PubMed ID: 8823825 [No Abstract] [Full Text] [Related]
17. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. Tung R; Zimetbaum P; Josephson ME J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736 [TBL] [Abstract][Full Text] [Related]
18. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)". Boriani G; Biffi M; Martignani C Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348 [No Abstract] [Full Text] [Related]
19. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Klein H; Auricchio A; Reek S; Geller C Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848 [TBL] [Abstract][Full Text] [Related]
20. Management of Brugada Syndrome 2016: Should All High Risk Patients Receive an ICD? All High-Risk Patients Should Receive an Implantable Cardiac Defibrillator. Sieira J; Brugada P Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906652 [No Abstract] [Full Text] [Related] [Next] [New Search]